Skip header and navigation

3 records – page 1 of 1.

Eye infections in newborns caused by gonorrhea and chlamydia

https://libcat.nshealth.ca/en/permalink/chpams36641
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2050
Available Online
View Pamphlet
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Ophthalmia Neonatorum - prevention & control
Subjects (LCSH)
Conjunctivitis, Infantile
Specialty
Gynecology
Abstract
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you can prevent your newborn from getting an eye infection caused by gonorrhea or chlamydia, how to know if your baby has an eye infection, and what to do if you think your newborn may have an eye infection. Resources for more information are included.
Responsibility
Prepared by: Women and Children’s Provincial Policy Working Group
Pamphlet Number
2050
Less detail

Neonatal abstinence syndrome

https://libcat.nshealth.ca/en/permalink/chpams36769
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2144
Available Online
View Pamphlet
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2144
Less detail

Syndrome de sevrage néonatal

https://libcat.nshealth.ca/en/permalink/chpams37507
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2203
Available Online
View Pamphlet
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison. ; This pamphlet is a French translation of the English pa…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
Neonatal abstinence syndrome
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison.
This pamphlet is a French translation of the English pamphlet 2144, "Neonatal abstinence syndrome". Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2203
Less detail